Latest Insider Transactions at 1 Life Healthcare Inc (ONEM)
This section provides a real-time view of insider transactions for 1 Life Healthcare Inc (ONEM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 1Life Healthcare Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 1Life Healthcare Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2023
|
Lisa A Mango General Counsel and Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
88,385
-100.0%
|
$1,590,930
$18.0 P/Share
|
|
Feb 22
2023
|
Amir Dan Rubin Chair, CEO and President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
99,748
-100.0%
|
$1,795,464
$18.0 P/Share
|
|
Feb 22
2023
|
Bjorn B Thaler Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,532
-100.0%
|
$387,576
$18.0 P/Share
|
|
Feb 22
2023
|
Vikas Agarwal Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,866
-100.0%
|
$159,588
$18.0 P/Share
|
|
Feb 22
2023
|
Andrew S Diamond Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,620
-100.0%
|
$425,160
$18.0 P/Share
|
|
Feb 22
2023
|
Scott C Taylor |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,753
-100.0%
|
$139,554
$18.0 P/Share
|
|
Feb 22
2023
|
Holmes Kalen |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,534
-100.0%
|
$81,612
$18.0 P/Share
|
|
Feb 22
2023
|
David P Kennedy |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
250,779
-100.0%
|
$4,514,022
$18.0 P/Share
|
|
Feb 22
2023
|
David P Kennedy |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,285
-100.0%
|
$185,130
$18.0 P/Share
|
|
Feb 22
2023
|
Freda C Lewis Hall |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,534
-100.0%
|
$81,612
$18.0 P/Share
|
|
Feb 22
2023
|
Mary Ann Tocio |
SELL
Sale (or disposition) back to the issuer
|
Direct |
47,298
-100.0%
|
$851,364
$18.0 P/Share
|
|
Feb 22
2023
|
Paul R. Auvil Iii |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,586
-100.0%
|
$226,548
$18.0 P/Share
|
|
Feb 22
2023
|
Mark S. Blumenkranz |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,534
-100.0%
|
$81,612
$18.0 P/Share
|
|
Feb 22
2023
|
Bruce Dunlevie |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
665,257
-100.0%
|
$11,974,626
$18.0 P/Share
|
|
Feb 22
2023
|
Bruce Dunlevie |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,586
-100.0%
|
$226,548
$18.0 P/Share
|
|
Feb 17
2023
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,150
-6.51%
|
$92,250
$15.32 P/Share
|
|
Feb 16
2023
|
Vikas Agarwal Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,117
-19.28%
|
$31,755
$15.36 P/Share
|
|
Feb 16
2023
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
7,596
-7.44%
|
$113,940
$15.36 P/Share
|
|
Feb 16
2023
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,015
-21.84%
|
$90,225
$15.36 P/Share
|
|
Feb 15
2023
|
Vikas Agarwal Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,132
+18.39%
|
-
|
|
Feb 15
2023
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,301
+20.77%
|
-
|
|
Feb 15
2023
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
13,746
+6.24%
|
-
|
|
Feb 15
2023
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,829
+33.42%
|
-
|
|
Jan 15
2023
|
Bruce Dunlevie |
BUY
Grant, award, or other acquisition
|
Direct |
1,051
+7.71%
|
-
|
|
Jan 15
2023
|
Scott C Taylor |
BUY
Grant, award, or other acquisition
|
Direct |
751
+8.83%
|
-
|
|
Jan 15
2023
|
Mary Ann Tocio |
BUY
Grant, award, or other acquisition
|
Direct |
751
+1.56%
|
-
|
|
Jan 15
2023
|
David P Kennedy |
BUY
Grant, award, or other acquisition
|
Direct |
751
+6.81%
|
-
|
|
Jan 15
2023
|
Paul R. Auvil Iii |
BUY
Grant, award, or other acquisition
|
Direct |
1,051
+7.71%
|
-
|
|
Dec 20
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,116
-30.84%
|
$97,856
$16.72 P/Share
|
|
Dec 01
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-1.0%
|
$3,400
$17.0 P/Share
|
|
Nov 21
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
4,102
-4.44%
|
$65,632
$16.58 P/Share
|
|
Nov 21
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,102
+2.19%
|
$45,122
$11.52 P/Share
|
|
Nov 17
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
4,312
-4.65%
|
$68,992
$16.71 P/Share
|
|
Nov 17
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
761
-3.66%
|
$12,176
$16.7 P/Share
|
|
Nov 16
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
4,230
-4.36%
|
$67,680
$16.82 P/Share
|
|
Nov 16
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,935
-15.91%
|
$62,960
$16.81 P/Share
|
|
Nov 15
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
11,014
+5.37%
|
$132,168
$12.16 P/Share
|
|
Nov 15
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,472
-2.72%
|
$39,552
$16.84 P/Share
|
|
Nov 15
2022
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,542
+45.29%
|
-
|
|
Nov 15
2022
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,251
+29.3%
|
-
|
|
Nov 01
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,417
-41.84%
|
$177,089
$17.1 P/Share
|
|
Nov 01
2022
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,417
+29.5%
|
$72,919
$7.93 P/Share
|
|
Oct 24
2022
|
Andrew S Diamond Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
293,185
-99.4%
|
$4,984,145
$17.08 P/Share
|
|
Oct 24
2022
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
184,211
+17.74%
|
$1,473,688
$8.66 P/Share
|
|
Oct 21
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,602
-1.78%
|
$27,234
$17.08 P/Share
|
|
Oct 21
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,602
+1.75%
|
$17,622
$11.56 P/Share
|
|
Oct 19
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,500
-2.75%
|
$42,500
$17.06 P/Share
|
|
Oct 19
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.68%
|
$27,500
$11.47 P/Share
|
|
Oct 17
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,472
-2.72%
|
$42,024
$17.06 P/Share
|
|
Oct 17
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,472
+2.65%
|
$29,664
$12.16 P/Share
|